Guanhao Biotech Co.,Ltd. (SHE:300238)
China · Delayed Price · Currency is CNY 12.10
+0.06 (0.50%)
Sep 23, 2026, 3:04 PM CST
Guanhao Biotech Market Cap
Guanhao Biotech has a market cap or net worth of 3.32 billion as of September 23, 2026. Its market cap has decreased by -19.13% in one year.
Market Cap
3.32B
Enterprise Value
3.23B
Revenue
361.40M
Ranking
n/a
PE Ratio
193.94
Stock Price
12.10
ChartMarket Cap Chart
Since July 6, 2011, Guanhao Biotech's market cap has increased from 2.74B to 3.32B, an increase of 21.13%. That is a compound annual growth rate of 1.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 3.21B | -12.64% |
| Dec 31, 2025 | 3.67B | 15.03% |
| Dec 31, 2024 | 3.19B | -11.21% |
| Dec 29, 2023 | 3.60B | 31.91% |
| Dec 30, 2022 | 2.73B | -44.52% |
| Dec 31, 2021 | 4.91B | -26.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lifecome Biochemistry | 3.64B |
| Landfar Bio-medicine | 3.63B |
| Shanghai Shen Lian Biomedical | 3.56B |
| Pulike Biological Engineering | 3.52B |
| Jiangsu Bioperfectus Technologies | 3.30B |
| Hinova Pharmaceuticals | 3.26B |
| Qingdao Vland Biotech INC. | 3.25B |
| Beijing Kawin Technology Share-Holding | 3.05B |